Nigella sativa pharmacological applications

Nigella sativa, a flowering plant native to Southwest Asia and the Mediterranean, has been used in traditional medicine for centuries, and researchers are now working to understand the molecular mechanisms behind its reported therapeutic effects. Much of the scientific attention has centered on thymoquinone, the plant's principal bioactive compound, which appears to exert antioxidant, anti-inflammatory, and immunomodulatory effects across a range of experimental models, with promising signals in cancer, diabetes, and neurodegenerative disease research. A central challenge is translating these findings from cell and animal studies into reliable clinical evidence, since questions about optimal dosing, bioavailability, and long-term safety in humans remain incompletely answered. Active work is also focused on whether thymoquinone can be reformulated — through nanoparticle delivery or other strategies — to improve its stability and therapeutic reach in the body.

Works

15,942

Total citations

180,597

Keywords

Nigella sativaThymoquinoneAntioxidantAnti-inflammatoryCancerImmunomodulatory